PeptideDB

m-Nifedipine 21881-77-6

m-Nifedipine 21881-77-6

CAS No.: 21881-77-6

m-Nifedipine is an impurity of Nifedipine (Bay-1040; BAY-a-1040; Cordipin; Corinfar) which is an approved dihydropyridin
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

m-Nifedipine is an impurity of Nifedipine (Bay-1040; BAY-a-1040; Cordipin; Corinfar) which is an approved dihydropyridine calcium channel blocker (CCB) used as antihypertensive drug.



Physicochemical Properties


Molecular Formula C₁₇H₁₈N₂O₆
Molecular Weight 346.33
Exact Mass 346.116
CAS # 21881-77-6
PubChem CID 89082
Appearance Off-white to light yellow solid powder
Density 1.3±0.1 g/cm3
Boiling Point 478.1±45.0 °C at 760 mmHg
Flash Point 242.9±28.7 °C
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.559
LogP 2.97
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 7
Rotatable Bond Count 5
Heavy Atom Count 25
Complexity 608
Defined Atom Stereocenter Count 0
InChi Key MCTRZKAKODSRLQ-UHFFFAOYSA-N
InChi Code

InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-6-5-7-12(8-11)19(22)23/h5-8,15,18H,1-4H3
Chemical Name

dimethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Synonyms

m-Nifedipine m Nifedipine
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Effect of azithromycin on gingival overgrowth induced by cyclosporine A + nifedipine combination therapy: A morphometric analysis in rats. J Indian Soc Periodontol. 2016 Jul-Aug;20(4):396-401.


Solubility Data


Solubility (In Vitro) Ethanol : ~5 mg/mL (~14.44 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 0.5 mg/mL (1.44 mM) (saturation unknown) in 10% EtOH + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear EtOH stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 0.5 mg/mL (1.44 mM) (saturation unknown) in 10% EtOH + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear EtOH stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.8874 mL 14.4371 mL 28.8742 mL
5 mM 0.5775 mL 2.8874 mL 5.7748 mL
10 mM 0.2887 mL 1.4437 mL 2.8874 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.